secwatch.observer — SEC 8-K summary
======================================

Issuer:     IGC Pharma, Inc. (IGC)
CIK:        0001326205
Form:       8-K
Filed at:   2025-10-14T23:59:59+00:00
Accession:  0001185185-25-001428
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IGC Pharma shareholders approve 4x increase in authorized shares to 600M and 5M share grant
--------------------------------------------------------------------------------

- Shareholders approved amendment to increase authorized common stock from 150M to 600M shares.
- Approved grant of up to 5M shares for employees, advisors, directors, and consultants under performance metrics.
- Re-elected directors Ram Mukunda and James Moran as Class C directors until 2028.
- Ratified Manohar Chowdhry & Associates as independent auditor for fiscal 2026.
- Non-binding advisory vote set frequency of executive compensation votes every three years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326205/000118518525001428/0001185185-25-001428-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326205/000118518525001428/igc8k101025.htm
  HTML page:      https://secwatch.observer/filing/0001185185-25-001428

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer